---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/251382913.md"
description: "Innovative drug concept stocks saw a partial rebound, with Hanyu Pharmaceutical surging over 10% in the afternoon, Hicin Pharmaceutical, Sun-Novo, and Guangshengtang also rising over 10%. Fuyuan Pharmaceutical and WEDGE CORPORATION hit the daily limit, while Longshen Rongfa, JINGXIN, CSBIO, and Staidson BioPharm followed suit"
datetime: "2025-08-04T05:09:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/251382913.md)
  - [en](https://longbridge.com/en/news/251382913.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/251382913.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/251382913.md) | [繁體中文](https://longbridge.com/zh-HK/news/251382913.md)


# 

Innovative drug concept stocks saw a partial rebound, with Hanyu Pharmaceutical surging over 10% in the afternoon, Hicin Pharmaceutical, Sun-Novo, and Guangshengtang rising over 10%, Fuyuan Pharmaceutical and WEDGE CORPORATION hitting the daily limit, and Longshen Rongfa, JINGXIN, CSBIO, Staidson BioPharm, and others following suit

### Related Stocks

- [Hicin Pharmaceutical (300584.CN)](https://longbridge.com/en/quote/300584.CN.md)
- [Sun-Novo (688621.CN)](https://longbridge.com/en/quote/688621.CN.md)
- [WEDGE CORPORATION (000534.CN)](https://longbridge.com/en/quote/000534.CN.md)
- [CSBIO (300255.CN)](https://longbridge.com/en/quote/300255.CN.md)
- [Staidson BioPharm (300204.CN)](https://longbridge.com/en/quote/300204.CN.md)
- [JINGXIN (002020.CN)](https://longbridge.com/en/quote/002020.CN.md)

## Related News & Research

- [Tajikistan Approves Hebei Changsha Biochemical Pharmaceutical's Thrombosis Injection](https://longbridge.com/en/news/278372421.md)
- [11 immigrants died in US ICE detention between January and March 2026](https://longbridge.com/en/news/278516593.md)
- [Aurobindo Pharma gets tax demand and penalty of 776.1 million rupees each](https://longbridge.com/en/news/279004326.md)
- [Clover Biopharmaceuticals Sets Board Meeting to Approve 2025 Results and Consider Dividend](https://longbridge.com/en/news/279032574.md)
- [Kennedy Center President Grenell to transition out of his role, Axios reports](https://longbridge.com/en/news/279085698.md)